# Cannabis (THC vs. CBD) in Multiple Sclerosis

> **NCT06261489** · PHASE2 · ACTIVE_NOT_RECRUITING · sponsor: **University of Calgary** · enrollment: 30 (estimated)

## Conditions studied

- Multiple Sclerosis

## Interventions

- **DRUG:** THC
- **DRUG:** CBD

## Key facts

- **NCT ID:** NCT06261489
- **Lead sponsor:** University of Calgary
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2025-12-05
- **Primary completion:** 2026-09
- **Final completion:** 2026-09
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2026-01-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06261489

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06261489, "Cannabis (THC vs. CBD) in Multiple Sclerosis". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT06261489. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*